Introducing PharmAlliance’s Cutting-Edge Roxithromycin Range

PharmAlliance International Labs Private Limited is thrilled to unveil our Roxithromycin Range, a formidable antibiotic designed to combat a wide array of bacterial infections. With our steadfast dedication to quality and innovation, we provide healthcare practitioners and patients with dependable solutions for addressing microbial challenges.

Understanding the Macrolide Class:

Delve into the realm of macrolides with Roxithromycin, a potent antibiotic belonging to this distinguished class renowned for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria. Acting as a bacteriostatic agent, Roxithromycin disrupts bacterial protein synthesis, effectively impeding the growth and proliferation of susceptible pathogens.

Tailored Formulations for Enhanced Flexibility:

Empower healthcare providers with our Roxithromycin Tablets, available in a versatile range of strengths including 50mg, 100mg, 150mg, and 300mg. These formulations offer flexible dosing options to accommodate diverse patient needs, ensuring precise and effective treatment regimens.

Optimized Packing Specifications:

Experience convenience and efficiency with our Roxithromycin Tablets, meticulously packaged in blister packs containing either 10 tablets or, for our 300mg strength, packs of 5 tablets. This streamlined packaging ensures ease of storage, handling, and administration, enhancing the overall treatment experience.

Indications Spanning Various Infections:

Unlock the potential of Roxithromycin in treating a myriad of bacterial infections, including upper and lower respiratory tract infections, skin and soft tissue infections, genitourinary tract infections, and uncomplicated genital infections. Our comprehensive range addresses critical clinical needs, facilitating optimal therapeutic outcomes.

Precise Dosage and Usage Guidelines:

Navigate treatment complexities with confidence, guided by precise dosage and usage recommendations tailored to infection type, severity, and patient characteristics. Roxithromycin tablets are administered orally with a full glass of water, ideally taken with food to minimize gastrointestinal side effects.

Dosage onsiderations for Individualized Care:

Ensure patient safety and efficacy with tailored dosage adjustments based on infection type, severity, and patient factors such as age and renal function. Special attention is given to patients with impaired hepatic function to mitigate the risk of drug accumulation and potential toxicity.

Awareness of Potential Side Effects:

Stay vigilant for potential side effects of Roxithromycin treatment, including gastrointestinal disturbances, headache, skin rash, and transient elevations in liver enzymes. While serious adverse effects such as hepatotoxicity and QT prolongation are rare, proactive monitoring and patient education are paramount for early detection and management.

Experience Excellence with PharmAlliance:

Embark on a journey of efficacy and safety with PharmAlliance International Labs Private Limited’s Roxithromycin Range. For further inquiries or to explore our range of pharmaceutical solutions, please do not hesitate to contact us.